Healthcare M&A transactions accelerated at a record pace to end Q1 2021 with a 52% increase over Q1 2020, showing 723 announced or closed transactions for the quarter, up from 476 transactions in Q1 2020. Topping the list were transactions in the life sciences and pharmaceuticals industries.
In the latest Bloomberg Law Insights report, FocalPoint Partners, joined by KPMG Deal Advisory and Epstein Becker & Green, P.C., discuss the outlook for healthcare M&A transactions in an environment impacted by economic recovery, the COVID-19 vaccine rollout, and possible healthcare system reforms. Read the full report at Bloomberg Health Law & Business: https://tinyurl.com/zh9zbcbs
About FocalPoint Healthcare Investment Banking
FocalPoint's Healthcare Investment Banking team provides differentiated M&A and transaction advisory services to a wide range of healthcare providers and organizations. Our experience includes advising healthcare entities across the country in the execution of M&A and capital markets transactions spanning from less-integrated strategic affiliations and joint ventures to fully-integrated membership substitutions, mergers, acquisitions, as well as debt and equity capital raising mandates. FocalPoint's mastery of the clinical, strategic and financial imperatives facing the healthcare industry enables us to serve a client base that includes community hospitals, regional and national healthcare systems, physician groups and practices, behavioral health providers, specialty pharmacies, home healthcare agencies, ambulatory surgery centers, and more.
For more information, visit focalpointllc.com/healthcare or contact a healthcare practice team member:
Hector Torres, Managing Director, htorres@focalpointllc.com